Drug Metabolism Letters
Title:Meet Our Editorial Board Member
Volume: 12 Issue: 2
Author(s): Kexin Liu
Affiliation:
Export Options
About this article
Cite this article as:
Liu Kexin , Meet Our Editorial Board Member, Drug Metabolism Letters 2018; 12 (2) . https://dx.doi.org/10.2174/187231281202181122155642
DOI https://dx.doi.org/10.2174/187231281202181122155642 |
Print ISSN 1872-3128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-0758 |
23
Related Articles
-
Vaccine Delivery - Current Trends and Future
Current Drug Delivery Calcium Antagonists: A Ready Prescription for Treating Infectious Diseases?
Current Topics in Medicinal Chemistry Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update
Current Cancer Drug Targets Towards Liver-Directed Gene Therapy for Crigler-Najjar Syndrome
Current Gene Therapy Bile Acids in Physiology, Pathology and Pharmacology
Current Drug Metabolism Carbocyclic Nucleosides (Carbanucleosides) as New Therapeutic Leads
Current Topics in Medicinal Chemistry Therapeutic Vaccines Explored in Patients with Non-Small Cell Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry Safety of Dipeptidyl Peptidase 4 Inhibitors for Treatment of Type 2 Diabetes
Current Drug Safety Essential Roles of Toll-Like Receptors in Atherosclerosis
Current Medicinal Chemistry Phenolic Profile, Acute Toxicity, and Hepatoprotective and Antiproliferative Activities of Algerian <i>Ruta tuberculata</i> Forssk
Current Bioactive Compounds The Potential Role of Gut Microbiota in the Pathogenesis of Type 2 Diabetes Mellitus <i>via</i> Epigenetics and Inflammasome
Endocrine, Metabolic & Immune Disorders - Drug Targets Polyphenolic Compounds: Interactions with the Gut and Implications for Human Health
Current Medicinal Chemistry Preface (Hot Topic: New Frontiers and ”Pitfalls“ in Cytokine and Anti-cytokine Therapies Executive Editor: Atsushi Oda)
Current Pharmaceutical Design APOE4: A Culprit for the Vulnerability of COVID-19 in Alzheimer's Patients
Current Neurovascular Research Therapeutic Applications of Liposomal Based Drug Delivery and Drug Targeting for Immune Linked Inflammatory Maladies: A Contemporary View Point
Current Drug Targets Recent Advances in Coumarins and 1-Azacoumarins as Versatile Biodynamic Agents
Current Medicinal Chemistry IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression
Current Drug Targets Glucagon Like Peptide-1 and Atherosclerosis
Cardiovascular & Hematological Agents in Medicinal Chemistry The Human Desmin Promoter Drives Robust Gene Expression for Skeletal Muscle Stem Cell-Mediated Gene Therapy
Current Gene Therapy Perspectives on Medicinal Properties of Mangiferin
Mini-Reviews in Medicinal Chemistry